Scrutiny

Fentanyl Narcotic Pain Patch under Scrutiny

Fentanyl skin patches (brand name Duragesic) a potent narcotic medication for pain management// is under FDA scrutiny after reports of deaths in patients using the patch were reported. The FDA says it is conducting an investigation into the deaths associated with these patches as it is unclear if the deaths are due to inappropriate use of the patch or factors related to the quality of the product...

Scrutiny Sought For Reused Devices in U.S.

A key member of the U.S. Congress called on Monday for more rigorous federal monitoring of reuse of single-use instruments.// The Food and Drug Administration (FDA) has been monitoring the industry -- called reprocessing -- but significant gaps remain, according to Rep. Rosa L. DeLauro (D-Conn.), the ranking Democrat on the House Appropriations subcommittee that oversees the FDA. <br...

Bausch & Lomb Facility under Scrutiny

Bausch & Lomb is one of the leading company which manufactures contact lens solution. But recently it was found that it caused serious eye infections in some users. // After this report the Food and Drug Administration (FDA) started to inspect Bausch & Lomb facilities. There was extensive microbiological testing conducted which would take up to one month to fully analyze the culprit behind the...

Use of Nanoparticles in Sunscreen under Scrutiny

Nanotechnology is the use of particles which are very small. They are submicroscopic particles which are thought to pose a health hazard. // The petition was raised by environmental groups which asked the Food and Drug Administration (FDA) to strengthen its regulation of sunscreens that contain nano-sized titanium dioxide and zinc oxide. These particles are thought to cause inflammatory and immun...

Drug-coated heart stents under scrutiny, after study

Barcelona: Experts from Spain are not too comfortable with the outcome of drug coated heart stents, once thought to be a saving grace//, could carry a risk of formation of fatal blood clots. The drug-coated stents were brought into the market in 2000 as an upgraded version of bare-metal stents. It is estimated that almost 6 million people worldwide have the drug-lined versions of th...

New Analysis Puts Cot Death Under Scrutiny Once Again

An analysis published in this weeks BMJ is set to re-open the debate over sudden unexpected infant death (cot death). The Lancet recently published a study on repeat infant deaths in 46 families, which suggested that almost 90% of second deaths in the same family are natural. These findings contrasted with earlier studies, which found a much higher proportion of repe...